![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Ovarian Neoplasms |
|
Free Subscription
1 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Extracellular vesicles derived from ovarian cancer cells promote tumor
progression through m2 macrophage polarization and enhanced angiogenesis.
BMC Cancer. 2026 Apr 24. doi: 10.1186/s12885-026-16059.
PubMed
A urinary three-metabolite signature enables non-invasive identification of
high-risk ovarian cancer patients.
Clin Cancer Res. 2026 Apr 24. doi: 10.1158/1078-0432.CCR-25-4260.
PubMed
Abstract available
Returning to PARP inhibition: Rechallenge with Bevacizumab in Ovarian Cancer.
Clin Cancer Res. 2026 Apr 23. doi: 10.1158/1078-0432.CCR-26-0534.
PubMed
Abstract available
Eur J Obstet Gynecol Reprod Biol
Opportunistic salpingectomy: Is surgical completeness achieved? Insights from the
QOS study.
Eur J Obstet Gynecol Reprod Biol. 2026;321:115066.
PubMed
Abstract available
Brenner borderline ovarian tumors: A series of seven cases and a literature
review.
Eur J Obstet Gynecol Reprod Biol. 2026;321:115044.
PubMed
Abstract available
Visual assessment of residual peritoneal disease during interval cytoreductive
surgery: a prospective comparison of gross visualisation and laparoscope-assisted
techniques.
Eur J Obstet Gynecol Reprod Biol. 2026;321:115034.
PubMed
Abstract available
Association of surgical complexity with patient-reported outcomes among patients
with ovarian cancer.
Gynecol Oncol. 2026;208:106-112.
PubMed
Abstract available
Identifying ovarian cancer with AI analysis of abdominal CT scans.
Gynecol Oncol. 2026;207S:30-37.
PubMed
Abstract available
The molecular profile of ovarian struma ovarii.
Hum Pathol. 2026;171:106069.
PubMed
Abstract available
Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in
Patients With Recurrent Platinum-Resistant Ovarian Cancer.
Int J Cancer. 2026 Apr 23. doi: 10.1002/ijc.70510.
PubMed
Abstract available
Correction: The splicing factor WBP11 mediates MCM7 intron retention to promote
the malignant progression of ovarian cancer.
Oncogene. 2026 Apr 23. doi: 10.1038/s41388-026-03810.
PubMed
Intraperitoneal administration of NK-92 improves survival in xenografts of early
and established ovarian cancer models.
PLoS One. 2026;21:e0347095.
PubMed
Abstract available
Analysis of ovarian cancer immune cell profile identifies immunosuppressive
states associated with adverse clinical attributes and survival times.
PLoS One. 2026;21:e0346746.
PubMed
Abstract available
Thank you for your interest in scientific medicine.